A classification of the fibrin network structures formed from the hereditary dysfibrinogens

Journal of Thrombosis and Haemostasis

Volumn 4, Issue 8, 2006, Pages 1738-1746

  Sugo, T ^a   Endo, H ^a   Matsuda, M ^a   Ohmori, T ^a   Madoiwa, S ^a   Mimuro, J ^a   Sakata, Yoichi ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Dysfibrinogen; Dysfibrinogenemia; Fibrin; Fibrinogen; Network

Indexed keywords

CALCIUM; FIBRIN; FIBRINOPEPTIDE A;

ARTICLE; BINDING SITE; BLOOD SAMPLING; CALCIUM BINDING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DYSFIBRINOGENEMIA; FIBRIN CLOT; GLYCOSYLATION; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; INCUBATION TIME; MECHANICAL STRESS; POROSITY; PRIORITY JOURNAL; PROTEIN SECRETION; SCANNING ELECTRON MICROSCOPY; TURBIDITY;

AFIBRINOGENEMIA; BLOOD COAGULATION; FIBRIN; FIBRINOGEN; FIBRINOGENS, ABNORMAL; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MICROSCOPY, ELECTRON, SCANNING; TIME FACTORS;

EID: 33746602187     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2006.02043.x     Document Type: Article

References (30)

1. Mosesson MW, Siebenlist KR, Meh DA. The structure and biological features of fibrinogen and fibrin. Ann N Y Acad Sci 2001; 936: 11-30.
2. Doolittle RF, Yang Z, Mochalkin I. Crystal structure studies on fibrinogen and fibrin. Ann N Y Acad Sci 2001; 936: 31-43.
3. Pratt KP, CôtéHCF, Chung DW, Stenkamp RE, Davie RE. The primary fibrin polymerization pocket: Three-dimensional structure of a 30-kDa C-terminal γ-chain fragment complexed with the peptide Gly-Pro-Arg-Pro. Proc Natl Acad Sci USA 1997; 94: 7176-81.
4. Spraggon G, Everse SJ, Doolittle RF. Crystal structure of fragment D from human fibrinogen and its cross-linked counterpart from fibrin. Nature 1997; 1389: 455-62.
5. Everse SJ, Spraggon G, Veerapandian L, Riley M, Doolittle RF. Crystal structure of fragment double-D from human fibrin with two different bound ligands. Biochemistry 1998; 37: 8637-42.
6. Brown JH, Volkmann N, Jun G, Henschen-Edman AH, Cohen C. The crystal structure of modified bovine fibrinogen. Proc Natl Acad Sci USA 2000; 97: 85-90.
7. Yang Z, Kollman J, Pandi L, Doolittle RF. Crystal structure of native chicken fibrinogen at 2.7 Å resolution. Biochemistry 2001; 40: 12515-23.
8. Madrazo J, Brown JH, Litvinovich S, Dominguez R, Yakovlev S, Medved L, Cohen C. Crystal structure of the central region of bovine fibrinogen (E5 fragment) at 1.4-Å resolution. Proc Natl Acad Sci USA 2001; 98: 11967-72.
9. Everse SJ, Spraggon G, Doolitle RF. A three-dimensional consideration of variant human fibrinogens. Thromb Haemost 1998; 80: 1-9.
10. Côté HCF, Lord ST, Pratt KP. Gamma-chain dysfibrinogenemias: Molecular structure-function relationships of naturally occurring mutations in the gamma chain of fibrinogen. Blood 1998; 92: 2195-212.
11. Matsuda M, Sugo T. Hereditary disorders of fibrinogen. Ann NY Acad Sci 2001; 936: 11-30.
12. Sugo T, Sakata Y, Matsuda M. Structural alterations in hereditary dysfibrinogens. Curr Protein Pept Sci 2003; 3: 239-47.
13. Scott EM, Ariëns RA, Grant PJ. Genetic environmental determinants of fibrin structure and function: Relevance to clinical disease. Arterioscler Thromb Vasc Biol 2004; 24: 1558-66.
14. Mosesson MW, DiOrio PJ, Muller MF, Shainoff JR, Siebenlist KR, Amrani DL, Homandberg GA, Soria J, Soria C, Samama M. Studies on the ultrastructure of fibrin lacking fibrinopeptide B (beta-fibrin). Blood 1987; 69: 1073-81.
15. Mosesson MW, Siebenlist KR, DiOrio JP, Matsuda M, Hainfeld JF, Wall JS. The role of fibrinogen D domain interaction association sites in the polymerization of fibrin and fibrinogen Tokyo II (γ275 Arg → Cys). J Clin Invest 1995; 96: 1053-58.
16. Collet JP, Woodhead JL, Soria J, Soria C, Mirshahi M, Caen JP, Weisel JW. Fibrinogen Dusart: Electron microscopy of molecules, fibers and clots, and viscoelastic properties of clots. Biophys J 1996; 70: 500-10.
17. Woodhead JL, Nagaswami C, Matsuda M, Arocha-Piñango CL, Weisel JW. The ultrastructure of fibrinogen Caracas II molecules, fibers, and clots. J Biol Chem 1996; 271: 4946-53.
18. Sugo T, Nakamikawa C, Takano H, Mimuro J, Yamaguchi S, Mosesson MW, Meh DA, DiOrio JP, Takahashi N, Takahashi H, Nagai K, Matsuda M. Fibrinogen Niigata with impaired fibrin assembly: An inherited dysfibrinogen with a Bβ Asn-160 to Ser substitution associated with extra glycosylation at Bβ Asn-158. Blood 1999; 94: 3806-13.
19. DiOrio JP, Mosesson MW, Hernandez I, Sugo T, Matsuda M. Fibrinogen Marburg fibrin network structure. Microsc Microanal 1999; 5: 1121-2.
20. Sugo T, Nakamikawa C, Yoshida N, Niwa K, Sameshima M, Mimuro J, Weisel JW, Nagita A, Matsuda M. End-linked homodimers in fibrinogen Osaka VI with a Bβ-chain extension lead to fragile clot structure. Blood 2000; 96: 3779-85.
21. Sugo T, Sekine O, Nakamikawa C, Endo H, Arocha-Piñango CL, Matsuda M. Mode of perturbation of Asahi fibrin assembly by the extra oligosaccharides. Ann NY Acad Sci 2001; 936: 223-5.
22. Marchi R, Arocha-Piñango CL, Nagy H, Matsuda M, Weisel JW. The effect of additional carbohydrate in the coiled-coil region on polymerization and clot structure and properties: Characterization of the homozygous and heterozygous forms of fibrinogen Lima (Aα Arg141 Ser with extra glycosylation). J Thromb Haemost 2004; 2: 940-8.
23. Hamano A, Mimuro J, Aoshima M, Ito T, Kitamura M, Nishinarita S, Takano K, Ishiwata A, Kashiwakura Y, Niwa K, Ono T, Madoiwa S, Sugo T, Matsuda M, Sakata Y. Thrombophilic dysfibrinogen Tokyo V with the amino acid substitution of γAla327Thr: Formation of fragile but fibrinolysis-resistant clots and its relevance to arterial thromboembolism. Blood 2004; 103: 3045-50.
24. Miyata T, Terukina S, Matsuda M, Kasamatsu A, Takeda Y, Iwanaga S. Fibrinogen Kawaguchi and Osaka: An amino acid substitution of Aα Arginine-16 to Cysteine which forms an extra interchain disulfide bridge between the two Aα chains. J Biochem 1987; 102: 93-101.
25. Terukina S, Matsuda M, Hirata H, Takeda Y, Miyata T, Takao T, Shimonishi Y. Substitution of γArg-275 by Cys in an abnormal fibrinogen, "Fibrinogen Osaka II" J Biol Chem 1988; 263: 13579-87.
26. Sugo T, Nakamikawa C, Takebe M, Kohno I, Egbring R, Matsuda M. Factor XIIIa cross-linking of the Marburg fibrin: Formation of αm-γn heteromultimers and the α-chain-linked albumin-γ complex, and disturbed protofibril assembly resulting in acquisition of plasmin resistance relevant to thrombophila. Blood 1998; 91: 3282-8.
27. Nilssen A. In Hypo-/Dysfibrinogenämie Giessen im Vergleich mit Hypo-/Dysfibrinogenämie Marburg. Doctorial dissertation. Giessen: Justus-Liebig University, 2002.
28. Yashida N, Hirata H, Morigami Y, Imaoka S, Matsuda M, Yamzumi K, Asakura S. Characterization of an abnormal fibrinogen Osaka V with the replacement of γ-Arginine 375 by Glycine. J Biol Chem 1992; 263: 2753-59.
29. Veklich YI, Gorkun OV, Medved LV, Nieuwebhuizen W, Weisel JW. Carboxyl-terminal portions of the α chains of fibrinogen and fibrin. Localization by electron microscopy and the effects of isolated α fragments on polymerization. J Biol Chem 1993; 268: 13577-85.
30. Marchi R, Meyer M, de Bosch N, Soria J, Arocha-Pinango CL, Weisel JW. Biophysical characterization of fibrinogen Caracas I with an Alpha-chain truncation at Aalpha-466 Ser: Identification of the mutation and biophysical characterization of properties of clots from plasma and purified fibrinogen. Blood Coagul Fibrinolysis 2004; 15: 285-93.